The Atlas · Editorial

Field Notes from the Atlas.

Sharper guides for navigating longevity tools, diagnostics, wearables, clinics, and healthspan decisions — without the hype.

Featured field note

This week's read.

The starting point we'd hand to anyone newly serious about healthspan.

Wearables / Biomarkers · 7 min read

What to track first if you actually want to optimize healthspan

The short list of signals that move the needle — and the ones safe to ignore for now.

WearablesBiomarkersBeginner Guides
Read the field note
Inside the note
  • 01 The signals worth tracking from week one
  • 02 What to defer until you have a baseline
  • 03 How to read your first 90 days of data

All field notes

6 notes — editorial, evidence-led, written to inform rather than sell.

Updated regularly
Editorial principles

How the Atlas reads the signal.

A short framework that shapes every field note, comparison, and listing on the Atlas.

01

Evidence over hype

We weight peer-reviewed research and clinical practice over marketing claims, influencer takes, and category enthusiasm.

02

Useful data over vanity metrics

A number is only worth tracking if it changes a decision. We highlight the signals that actually shift behavior or care.

03

Context over isolated numbers

One biomarker, one night of sleep, one scan — none of these mean much alone. We read them inside the bigger picture.

04

Better decisions over more dashboards

More charts rarely produce better outcomes. The Atlas exists to sharpen choices, not to crowd them.

Explore the Atlas

Bring a sharper map to the next decision.

Compare credible tools, diagnostics, clinics, programs, and education across the healthspan landscape.